Biotech M&A is booming in 2026, driven by patent cliffs and market recovery, signaling the strongest dealmaking since 2019.
Read More

Biotech M&A is booming in 2026, driven by patent cliffs and market recovery, signaling the strongest dealmaking since 2019.
Read More
Discover why private equity stocks are falling as withdrawal limits spark renewed liquidity concerns across major investment firms.
Read More
Andrew Left, founder of Citron Research, was convicted of securities fraud for manipulating stock prices through false information.
Read More
Abivax shares dropped significantly after new clinical trial data for its ulcerative colitis drug revealed cancer concerns, impacting its future.
Read More
SoftBank Group CEO Masayoshi Son declared on Monday that the ongoing artificial intelligence revolution will be 50 times larger than…
Read More
Wall Street rallies despite Middle East tensions and surging oil prices after US-Iran strikes; discover how markets are navigating this…
Read More
Market Warning Signs European stock markets are bracing for a potential downturn as a proprietary price momentum gauge from Bank…
Read More
European stock markets opened with a downward trend on Tuesday as investors grappled with persistent uncertainty surrounding U.S.-Iran diplomatic negotiations…
Read More
The Electric Challenge at Maranello Ferrari, the iconic Italian manufacturer of high-performance luxury sports cars, faces intensified investor scrutiny this…
Read More